Insys Therapeutics Inc. – NASDAQ:INSY

Insys Therapeutics stock price today

0.86
+0.56
+186.67%
Financial Health
0
1
2
3
4
5
6
7
8
9

Insys Therapeutics stock price yearly change

-93.32%
year

Insys Therapeutics key metrics

Market Cap
63.52M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-3.06
Revenue
65.79M
EBITDA
-221.32M
Income
-227.98M
Revenue Q/Q
-68.09%
Revenue Y/Y
-48.85%
Profit margin
-346.48%
Oper. margin
-349.73%
Gross margin
79.98%
EBIT margin
-349.73%
EBITDA margin
-336.37%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Insys Therapeutics stock price history

Insys Therapeutics stock forecast

Insys Therapeutics financial statements

Insys Therapeutics Inc. (NASDAQ:INSY): Profit margin
Jun 2018 23.46M -27.35M -116.55%
Sep 2018 18.34M -30.49M -166.22%
Dec 2018 16.35M -46.29M -283.02%
Mar 2019 7.63M -123.84M -1623.12%
Insys Therapeutics Inc. (NASDAQ:INSY): Debt to assets
Jun 2018 235145000 210.50M 89.52%
Sep 2018 217491000 217.35M 99.94%
Dec 2018 192527000 235.62M 122.39%
Mar 2019 172600000 336.32M 194.86%
Insys Therapeutics Inc. (NASDAQ:INSY): Cash Flow
Jun 2018 -22.65M 19.07M 1.12M
Sep 2018 -8.62M 13.26M 116K
Dec 2018 -7.30M 17.63M 376K
Mar 2019 -16.65M 21.60M 18K

Insys Therapeutics other data

Insys Therapeutics Inc. (NASDAQ:INSY): Insider trades (number of shares)
Period Buy Sel
Jun 2017 5400 0
Aug 2017 23000 0
May 2018 0 166504
Transaction Date Insider Security Shares Price per share Total value Source
Option
TAMBI BRIAN director
Stock Option (right to buy) 33,654 N/A N/A
Sale
TAMBI BRIAN director
Common Stock 166,504 N/A N/A
Option
TAMBI BRIAN director
Common Stock 162,504 N/A N/A
Purchase
JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989 10 percent owner
Common Stock 17,500 N/A N/A
Purchase
MOTAHARI SAEED director, officer: President & ..
Common Stock 5,500 N/A N/A
Option
FOURTEAU PATRICK director
Stock Option (right to buy) 10,000 N/A N/A
Option
FOURTEAU PATRICK director
Common Stock 10,000 N/A N/A
Purchase
MOTAHARI SAEED director, officer: President & ..
Common Stock 5,400 N/A N/A
Purchase
VISHNOI ROHIT director
Common Stock 4,000 N/A N/A
Option
FOURTEAU PATRICK director
Stock Option (right to buy) 10,000 N/A N/A
  • What's the price of Insys Therapeutics stock today?

    One share of Insys Therapeutics stock can currently be purchased for approximately $0.86.

  • When is Insys Therapeutics's next earnings date?

    Unfortunately, Insys Therapeutics's (INSY) next earnings date is currently unknown.

  • Does Insys Therapeutics pay dividends?

    No, Insys Therapeutics does not pay dividends.

  • How much money does Insys Therapeutics make?

    Insys Therapeutics has a market capitalization of 63.52M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 41.66% to 82.08M US dollars.

  • What is Insys Therapeutics's stock symbol?

    Insys Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "INSY".

  • What is Insys Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Insys Therapeutics?

    Shares of Insys Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • What is Insys Therapeutics's official website?

    The official website for Insys Therapeutics is insysrx.com.

Insys Therapeutics company profile:

Insys Therapeutics Inc.

insysrx.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare


,

CIK: 0001516479
ISIN: US45824V2097
: